OTC medicines sales in community pharmacy could increase significantly in the future, GSK has suggested. The company has pledged to work closely with the sector to “help pharmacists unlock incremental sales”.

Area general manager, northern Europe, David Barnett comments: “This is a time of change for pharmacy – we understand the challenges faced by our colleagues on the front line and have identified an £80 million growth opportunity for OTC medicines by maximising the potential of categories which aren’t performing as well within pharmacy. The multi-million pound investment we put behind our leading pharmacy brands is therefore more important than ever.”

Last year the company launched its Pharmacy of the Future vision, offering retailing insight from the Shopper Science Lab.